Alkermes to Host Conference Call to Discuss First Quarter 2015 Financial Results
April 23 2015 - 4:00PM
Business Wire
Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:30
a.m. EDT (1:30 p.m. BST) on Thursday, April 30, 2015, to discuss
the company’s first quarter 2015 financial results. Management will
also provide an update on the company.
The conference call will be webcast on the Investors section of
Alkermes’ website at www.alkermes.com or may be accessed by dialing
+1 888 424 8151 for U.S. callers and +1 847 585 4422 for
international callers. The conference call ID number is
6037988.
A replay of the conference call will be available from 11:00
a.m. EDT (4:00 p.m. BST) on Thursday, April 30, 2015, through 5:00
p.m. EDT (10:00 p.m. BST) on Thursday, May 7, 2015, and may be
accessed by visiting Alkermes’ website or by dialing +1 888 843
7419 for U.S. callers and +1 630 652 3042 for international
callers. The replay access code is 6037988.
About Alkermes plc
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases. The company has
a diversified commercial product portfolio and a substantial
clinical pipeline of product candidates for chronic diseases that
include schizophrenia, depression, addiction and multiple
sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing
facility in Wilmington, Ohio. For more information, please visit
Alkermes’ website at www.alkermes.com.
Alkermes Contact:Eva Stroynowski, +1-781-609-6823Corporate
Communications
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Apr 2023 to Apr 2024